Evaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115070 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Rana Hanna Al-Shaikh und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA. Hauptthemen laut MEDLINE: Neurofilament Proteins, Glial Fibrillary Acidic Protein, Spinocerebellar Ataxias. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, Donald G. and Jodi P. Heeringa Family.
Abstract (Originalsprache)
Spinocerebellar ataxia type 7 (SCA7), a rare form of ataxia, possesses a wide phenotypic spectrum ranging from classic ataxic symptoms to blindness, multiorgan failure, cardiomyopathy, and early death among younger age groups. Biomarkers associated with disease progression and severity could aid in disease prognostication. We evaluated the utility of glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) in distinguishing patients with SCA7 from healthy controls and estimating patient prognosis. GFAP and NfL levels were measured in 23 plasma and 20 cerebrospinal fluid (CSF) samples from asymptomatic (N = 3) and symptomatic SCA7 participants (N = 10) and from healthy controls (N = 8). GFAP concentrations were elevated in the plasma (82.7 pg/mL) and CSF (9318 pg/mL) of patients with SCA7 compared to controls (plasma: 48.0 pg/mL; CSF: 89,056 pg/mL). Similarly, NfL plasma (21.6 pg/mL) and CSF (2615.0 pg/mL) levels were also significantly upregulated in SCA7 compared to controls (plasma: 8.2 pg/mL; CSF: 414.6 pg/mL). Higher levels of NfL, but not of GFAP, significantly discriminated symptomatic SCA7 patients from controls (area under de curve, AUC: 0.898, p = 0.0059, in plasma, and AUC: 1.0, p = 0.0012, in CSF). The levels of both biomarkers increased overtime, with plasma NfL levels strongly associated with a worse score in the scale for the assessment and rating of ataxia (SARA) (Spearman r: 0.8354, p = 0.0007; regression analysis: β: 0.021, 95% CI: 0.008–0.035, p = 0.0048). These findings suggest that NfL could serve as a valuable biomarker for monitoring disease progression and prognosis in SCA7 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
- Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA.
- Neuroscience Graduate Program, Mayo Graduate School, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA.
- Department of Science, University of Barcelona, 08007 Barcelona, Spain.
- Movement Disorders Unit, Neurology Service, Internal Medicine Department, Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-90, PR, Brazil.
- Division of Neurological and Psychiatric Nursing, Medical University of Gdańsk, 80-211 Gdansk, Poland.
ORCID-Profile: Rana Hanna Al-Shaikh, Judith A Dunmore, Helio A G Teive, Zbigniew K Wszolek, Mercedes Prudencio
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- Donald G. and Jodi P. Heeringa Family
- National Institutes of Health
- Target ALS Foundation
- BrightFocus Foundation
- Robert Packard Center for ALS Research at Johns Hopkins
- NIH/NIA
Zitieren
APA
Hanna Al-Shaikh, R., Jansen-West, K., Strongosky, A., Parrales, Z., Dunmore, J. A., Song, Y., Gendron, T. F., Guevara, J. C., Teive, H. A. G., Dulski, J., Sławek, J., Petrucelli, L., Wszolek, Z. K., & Prudencio, M. (2025). Evaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115070
Vancouver
Hanna Al-Shaikh R, Jansen-West K, Strongosky A, Parrales Z, Dunmore JA, Song Y, et al. Evaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115070
BibTeX
@article{HannaAlShaikh2025,
author = {Hanna Al-Shaikh, Rana and Jansen-West, Karen and Strongosky, Audrey and Parrales, Zoe and Dunmore, Judith A and Song, Yuping and Gendron, Tania F and Guevara, Juan C and Teive, Helio A G and Dulski, Jarosław and Sławek, Jarosław and Petrucelli, Leonard and Wszolek, Zbigniew K and Prudencio, Mercedes},
title = {Evaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115070}
}
EUVIMED